Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Greg Roche
Distalmotion Secures Up to $70 Million Term Loan Facility from Perceptive Advisors to Accelerate US ASC Expansion Original
Lausanne, Switzerland, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company focused on expanding access to robotic surgery in outpatient settings, today announced that it has entered into a senior secured term loan facility of up to $70 million with Perceptive Advisors (“Perceptive”), a leading global healthcare investment firm.
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair Original
Lausanne, Switzerland, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System. The clearance was supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) Study.
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair
Lausanne, Switzerland, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System. The clearance was supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) Study.
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair News provided by Distalmotion Aug 13, 2026, 9:00 AM ET Lausanne, Switzerland, Aug.
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair
Lausanne, Switzerland, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System. The clearance was supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) Study.
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair
Lausanne, Switzerland, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System. The clearance was supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) Study.
Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications Original
Lausanne, Switzerland, June 16, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection for the DEXTER® Robotic Surgery System.
Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers
Lausanne, Switzerland, May 21, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company focused on empowering access to robotic surgery in outpatient settings, announced continued commercial progress in the US, with growing adoption of the DEXTER® Robotic Surgery System across ambulatory surgery centers (ASCs).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Greg
Contact Greg, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack